Foundation Medicine, a cancer diagnostics developer backed by Bill Gates, has filed paperwork for an initial public offering. The company's Foundation One product uses genomics data to personalize cancer treatments.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||